Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Trigriluzole
2. Bhv-4157a
3. Troriluzole [usan]
4. 1926203-09-9
5. Bhv-4157
6. S7h48s6k7h
7. Troriluzole (usan)
8. Glycinamide, Glycylglycyl-n2-methyl-n-(6-(trifluoromethoxy)-2-benzothiazolyl)-
9. Troriluzol
10. Troriluzole [inn]
11. Unii-s7h48s6k7h
12. Bhv4157a
13. Troriluzole [who-dd]
14. Chembl4297586
15. Schembl18154275
16. Gtpl11375
17. Bhv4157
18. Db15079
19. Fc-4157
20. Sb19816
21. Hy-122487
22. Cs-0085735
23. D11414
24. Q56407722
25. Glycylglycyl-n2-methyl-n-(6-(trifluoromethoxy)-1,3-benzothiazol-2-yl)glycinamide
26. 2-(2-aminoacetamido)-n-methyl-n-(2-oxo-2-((6-(trifluoromethoxy)benzo[d]thiazol-2-yl)amino)ethyl)acetamide
| Molecular Weight | 419.4 g/mol |
|---|---|
| Molecular Formula | C15H16F3N5O4S |
| XLogP3 | 1 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 7 |
| Exact Mass | 419.08750967 g/mol |
| Monoisotopic Mass | 419.08750967 g/mol |
| Topological Polar Surface Area | 155 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 595 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Troriluzole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Troriluzole, including repackagers and relabelers. The FDA regulates Troriluzole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Troriluzole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Troriluzole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Troriluzole supplier is an individual or a company that provides Troriluzole active pharmaceutical ingredient (API) or Troriluzole finished formulations upon request. The Troriluzole suppliers may include Troriluzole API manufacturers, exporters, distributors and traders.
click here to find a list of Troriluzole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Troriluzole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Troriluzole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Troriluzole GMP manufacturer or Troriluzole GMP API supplier for your needs.
A Troriluzole CoA (Certificate of Analysis) is a formal document that attests to Troriluzole's compliance with Troriluzole specifications and serves as a tool for batch-level quality control.
Troriluzole CoA mostly includes findings from lab analyses of a specific batch. For each Troriluzole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Troriluzole may be tested according to a variety of international standards, such as European Pharmacopoeia (Troriluzole EP), Troriluzole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Troriluzole USP).
LOOKING FOR A SUPPLIER?
